Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sobel

Showing results (41-50 of 1,014) with videos related to

Pageof 102
Sort By:
Journal of the American College of Cardiology|October 1, 1989
Coronary thrombolysis and the new biologyB E Sobel
The American Journal of Nursing|January 1, 1974
Death and dyingD E Sobel
Journal of the American College of Cardiology|November 1, 1987
Safety and efficacy of tissue-type plasminogen activator produced by recombinant DNA technologyB E Sobel
Circulation|August 1, 1987
Pharmacologic thrombolysis: tissue-type plasminogen activatorB E Sobel
Coronary Artery Disease|February 1, 1997
How does the coagulation system really work and why should we care?B E Sobel
Seminars in Cancer Biology|October 1, 1993
Differential expression of the 67 kDa laminin receptor in cancerM E Sobel
Postgraduate Medical Journal|January 1, 1992
Positron-emission tomography and cardiomyopathyB E Sobel
Coronary Artery Disease|July 28, 1999
Biomarkers, surrogates, and evaluation of therapeutic agents: a proposed solutionB E Sobel
Diabetes Care|April 30, 2003
Coronary disease in type 1 diabetes: causal contiguity and clinical implicationsBurton E Sobel
Advances in Cardiology|January 1, 1975
Quantification of myocardial ischemic injuryB E Sobel
Pageof 102

Showing results (41-50 of 1,014) with videos related to

Sort By:
Pageof 102
Journal of the American College of Cardiology|October 1, 1989
Coronary thrombolysis and the new biologyB E Sobel
The American Journal of Nursing|January 1, 1974
Death and dyingD E Sobel
Journal of the American College of Cardiology|November 1, 1987
Safety and efficacy of tissue-type plasminogen activator produced by recombinant DNA technologyB E Sobel
Circulation|August 1, 1987
Pharmacologic thrombolysis: tissue-type plasminogen activatorB E Sobel
Coronary Artery Disease|February 1, 1997
How does the coagulation system really work and why should we care?B E Sobel
Seminars in Cancer Biology|October 1, 1993
Differential expression of the 67 kDa laminin receptor in cancerM E Sobel
Postgraduate Medical Journal|January 1, 1992
Positron-emission tomography and cardiomyopathyB E Sobel
Coronary Artery Disease|July 28, 1999
Biomarkers, surrogates, and evaluation of therapeutic agents: a proposed solutionB E Sobel
Diabetes Care|April 30, 2003
Coronary disease in type 1 diabetes: causal contiguity and clinical implicationsBurton E Sobel
Advances in Cardiology|January 1, 1975
Quantification of myocardial ischemic injuryB E Sobel
Pageof 102